Gabelli Funds’s Meridian Bioscience Inc VIVO Stock Holding History

Gabelli Funds’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-208,265	Closed	-$6.92M	–	1249
2022 Q4	$6.92M	Sell	208,265 -15,250	-7%	-$491K	0.05%	385
2022 Q3	$7.05M	Buy	223,515 +139,515	+166%	+$4.52M	0.06%	371
2022 Q2	$2.56M	Hold	84,000	–	–	0.02%	618
2022 Q1	$2.18M	Hold	84,000	–	–	0.01%	699
2021 Q4	$1.71M	Hold	84,000	–	–	0.01%	765
2021 Q3	$1.62M	Hold	84,000	–	–	0.01%	786
2021 Q2	$1.86M	Buy	84,000 +1,000	+1%	+$21.2K	0.01%	772
2021 Q1	$2.18M	Buy	83,000 +1,000	+1%	+$23.8K	0.01%	707
2020 Q4	$1.53M	Sell	82,000 -8,500	-9%	-$159K	0.01%	776
2020 Q3	$1.54M	Sell	90,500 -10,000	-10%	-$194K	0.01%	737
2020 Q2	$2.34M	Sell	100,500 -15,000	-13%	-$217K	0.02%	618
2020 Q1	$970K	Sell	115,500 -1,000	-0.9%	-$8.42K	0.01%	788
2019 Q4	$1.14M	Buy	116,500 +20,000	+21%	+$188K	0.01%	831
2019 Q3	$916K	Sell	96,500 -29,000	-23%	-$306K	0.01%	867
2019 Q2	$1.49M	Sell	125,500 -43,500	-26%	-$524K	0.01%	822
2019 Q1	$2.98M	Sell	169,000 -15,000	-8%	-$250K	0.02%	662
2018 Q4	$3.19M	Sell	184,000 -8,000	-4%	-$136K	0.02%	624
2018 Q3	$2.86M	Sell	192,000 -4,000	-2%	-$62K	0.02%	713
2018 Q2	$3.12M	Sell	196,000 -8,000	-4%	-$119K	0.02%	684
2018 Q1	$2.9M	Sell	204,000 -4,000	-2%	-$59.2K	0.02%	689
2017 Q4	$2.91M	Buy	208,000 +4,000	+2%	+$58.6K	0.02%	695
2017 Q3	$2.92M	Hold	204,000	–	–	0.02%	699
2017 Q2	$3.21M	Hold	204,000	–	–	0.02%	672
2017 Q1	$2.81M	Hold	204,000	–	–	0.02%	702
2016 Q4	$3.61M	Hold	204,000	–	–	0.02%	630
2016 Q3	$3.94M	Hold	204,000	–	–	0.02%	613
2016 Q2	$3.98M	Hold	204,000	–	–	0.02%	611
2016 Q1	$4.2M	Buy	204,000 +4,000	+2%	+$78.8K	0.03%	584
2015 Q4	$4.1M	Buy	200,000 +5,000	+3%	+$95.9K	0.02%	587
2015 Q3	$3.33M	Hold	195,000	–	–	0.02%	635
2015 Q2	$3.63M	Hold	195,000	–	–	0.02%	656
2015 Q1	$3.72M	Buy	195,000 +25,000	+15%	+$462K	0.02%	661
2014 Q4	$2.8M	Buy	170,000 +30,000	+21%	+$515K	0.01%	716
2014 Q3	$2.48M	Buy	140,000 +5,000	+4%	+$98.2K	0.01%	747
2014 Q2	$2.79M	Buy	135,000 +45,000	+50%	+$925K	0.01%	723
2014 Q1	$1.96M	Buy	90,000 +61,000	+210%	+$1.4M	0.01%	764
2013 Q4	$769K	Hold	29,000	–	–	﹤0.01%	879
2013 Q3	$685K	Hold	29,000	–	–	﹤0.01%	889
2013 Q2	$624K	Buy	+29,000	New	+$625K	﹤0.01%	889

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Gabelli Funds's VIVO Position: Q1 2023 in Review

Gabelli Funds sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 208,265 shares — an estimated $6.92M sold.

Gabelli Funds first reported a position in VIVO in Q2 2013 and held it in 39 quarters. The position peaked at $7.05M in Q3 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Gabelli Funds reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Gabelli Funds sold 208,265 Meridian Bioscience Inc shares in Q1 2023, an estimated $6.92M.
Gabelli Funds first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 39 quarters.
Gabelli Funds's Meridian Bioscience Inc position peaked at $7.05M in Q3 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Gabelli Funds's 13F filing for Q1 2023, filed 12 May 2023.